All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Sourced from donors with Systemic Sclerosis, these CD56+ NK cells provide a unique window into the innate immune regulation of fibrosis. The cells are isolated to ensure maximum viability for functional assays focusing on NK-mediated inhibition of collagen synthesis or their direct cytotoxic effects on pathogenic myofibroblasts. This product is vital for understanding the transition from vascular injury to irreversible tissue scarring.
There are currently no customer reviews or questions for CellRapeutics™ CD56+ NK Cells from Scleroderma Donor (XS-0426-XU301). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION